Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Am J Kidney Dis
2008 Dec 01;526:1096-103. doi: 10.1053/j.ajkd.2008.07.041.
Show Gene links
Show Anatomy links
Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.
Monico CG
,
Weinstein A
,
Jiang Z
,
Rohlinger AL
,
Cogal AG
,
Bjornson BB
,
Olson JB
,
Bergstralh EJ
,
Milliner DS
,
Aronson PS
.
???displayArticle.abstract???
BACKGROUND: Urinary oxalate is a major risk factor for calcium oxalate stones. Marked hyperoxaluria arises from mutations in 2 separate loci, AGXT and GRHPR, the causes of primary hyperoxaluria (PH) types 1 (PH1) and 2 (PH2), respectively. Studies of null Slc26a6(-/-) mice have shown a phenotype of hyperoxaluria, hyperoxalemia, and calcium oxalate urolithiasis, leading to the hypothesis that SLC26A6 mutations may cause or modify hyperoxaluria in humans.
STUDY DESIGN: Cross-sectional case-control.
SETTING & PARTICIPANTS: Cases were recruited from the International Primary Hyperoxaluria Registry. Control DNA samples were from a pool of adult subjects who identified themselves as being in good health.
PREDICTOR: PH1, PH2, and non-PH1/PH2 genotypes in cases.
OUTCOMES & MEASURES: Homozygosity or compound heterozygosity for SLC26A6 variants. Functional expression of oxalate transport in Xenopus laevis oocytes.
RESULTS: 80 PH1, 6 PH2, 8 non-PH1/PH2, and 96 control samples were available for SLC26A6 screening. A rare variant, c.487C-->T (p.Pro163Ser), was detected solely in 1 non-PH1/PH2 pedigree, but this variant failed to segregate with hyperoxaluria, and functional studies of oxalate transport in Xenopus oocytes showed no transport defect. No other rare variant was identified specifically in non-PH1/PH2. Six additional missense variants were detected in controls and cases. Of these, c.616G-->A (p.Val206Met) was most common (11%) and showed a 30% reduction in oxalate transport. To test p.Val206Met as a potential modifier of hyperoxaluria, we extended screening to PH1 and PH2. Heterozygosity for this variant did not affect plasma or urine oxalate levels in this population.
LIMITATIONS: We did not have a sufficient number of cases to determine whether homozygosity for p.Val206Met might significantly affect urine oxalate.
CONCLUSIONS: SLC26A6 was effectively ruled out as the disease gene in this non-PH1/PH2 cohort. Taken together, our studies are the first to identify and characterize SLC26A6 variants in patients with hyperoxaluria. Phenotypic and functional analysis excluded a significant effect of identified variants on oxalate excretion.
Chernova,
Functional comparison of mouse slc26a6 anion exchanger with human SLC26A6 polypeptide variants: differences in anion selectivity, regulation, and electrogenicity.
2005, Pubmed,
Xenbase
Chernova,
Functional comparison of mouse slc26a6 anion exchanger with human SLC26A6 polypeptide variants: differences in anion selectivity, regulation, and electrogenicity.
2005,
Pubmed
,
Xenbase
Clark,
Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis.
2008,
Pubmed
,
Xenbase
Curhan,
24-h uric acid excretion and the risk of kidney stones.
2008,
Pubmed
Freel,
Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice.
2006,
Pubmed
Goldfarb,
A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry.
2005,
Pubmed
Haleblian,
Nephrolithiasis in identical twins: the impact of nature vs nurture.
2007,
Pubmed
Hassan,
Regulation of anion exchanger Slc26a6 by protein kinase C.
2007,
Pubmed
,
Xenbase
HERRING,
Observations on the analysis of ten thousand urinary calculi.
1962,
Pubmed
Hiatt,
The frequency of kidney and urinary tract diseases in a defined population.
1982,
Pubmed
Jiang,
Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6.
2006,
Pubmed
Jiang,
Specificity of anion exchange mediated by mouse Slc26a6.
2002,
Pubmed
,
Xenbase
Johnson,
Renal stone epidemiology: a 25-year study in Rochester, Minnesota.
1979,
Pubmed
Karniski,
Immunolocalization of sat-1 sulfate/oxalate/bicarbonate anion exchanger in the rat kidney.
1998,
Pubmed
Knauf,
Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells.
2001,
Pubmed
,
Xenbase
Kocinsky,
NHE3 phosphorylation at serines 552 and 605 does not directly affect NHE3 activity.
2007,
Pubmed
Lohi,
Mapping of five new putative anion transporter genes in human and characterization of SLC26A6, a candidate gene for pancreatic anion exchanger.
2000,
Pubmed
Lohi,
Isoforms of SLC26A6 mediate anion transport and have functional PDZ interaction domains.
2003,
Pubmed
,
Xenbase
Monga,
Renal stone risk in a simulated microgravity environment: impact of treadmill exercise with lower body negative pressure.
2006,
Pubmed
Monga,
Genetic heritability of urinary stone risk in identical twins.
2006,
Pubmed
Monico,
Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
2002,
Pubmed
Robertson,
Importance of mild hyperoxaluria in the pathogenesis of urolithiasis--new evidence from studies in the Arabian peninsula.
1993,
Pubmed
Robertson,
Risk factors in calcium stone disease of the urinary tract.
1978,
Pubmed
Robertson,
The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?
1980,
Pubmed
Rumsby,
Oxalate transport as contributor to primary hyperoxaluria: the jury is still out.
2008,
Pubmed
Soucie,
Demographic and geographic variability of kidney stones in the United States.
1994,
Pubmed
Trudeau,
HERG, a human inward rectifier in the voltage-gated potassium channel family.
1995,
Pubmed
Van Acker,
Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: a novel type of primary hyperoxaluria.
1996,
Pubmed
Waldegger,
Cloning and characterization of SLC26A6, a novel member of the solute carrier 26 gene family.
2001,
Pubmed
,
Xenbase
Wang,
Identification of an apical Cl(-)/HCO3(-) exchanger in the small intestine.
2002,
Pubmed
,
Xenbase
Wilson,
Modified enzyme-based colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: reference values and sample handling procedures.
1991,
Pubmed
Xie,
Molecular characterization of the murine Slc26a6 anion exchanger: functional comparison with Slc26a1.
2002,
Pubmed
,
Xenbase
